Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
VRP.L Share News (VRP)
VRP Share
Price
VRP Share
News
VRP Share
Chat
VRP Share
Trades
VRP
Live RNS
VRP Share
Charts
VRP Broker
Ratings
VRP Directors
Deals
VRP Financial
Diary
VRP
Fundamentals
VRP Short
Positions
VRP
Media
VRP Company
Research
VRP Company
Timeline
- There is currently no data for VRP
VRP.L News
Verona Pharma Shares Jump 15% On Positive Ensifentrine Study Results
(Alliance News) - Verona Pharma PLC on Monday reported positive second phase test data for a dry powder inhaler formulation of its lead development pr...
Verona Pharma strengthens clinical team ahead of next round of trials
(Sharecast News) - Respiratory-focussed biopharmaceutical company Verona Pharma announced two senior appointments to its clinical team on Tuesday.
Director dealings: Piers Morgan's spouse ups stake in Verona Pharma
(Sharecast News) - Verona Pharma revealed on Wednesday that chief financial officer Piers Morgan's wife Kayt Morgan had acquired 33,802 ordinary share...
Verona Pharma announces next study of nebulised ensifentrine
(Sharecast News) - Clinical-stage biopharmaceutical company Verona Pharma announced the initiation of a phase 2b dose-ranging study evaluating nebulis...
Verona Pharma Gets EU Patent For COPD Clinical Candidate Ensifentrine
LONDON (Alliance News) - Verona Pharma PLC on Tuesday said it secured a key patent from the European Patent Office relating to its lead development ca...
Verona Pharma gets another European patent on ensifentrine
(Sharecast News) - Respiratory disease-focussed clinical stage biopharmaceutical company Verona Pharma announced on Tuesday that the European Patent O...
DIRECTOR DEALINGS: Verona Pharma Chair David Ebsworth Buys Shares
LONDON (Alliance News) - Clinical-stage biopharmaceutical company Verona Pharma PLC said on Thursday Chair David Ebsworth bought 26,300 shares for 56....
Monday broker round-up
(Sharecast News) - RSA Insurance Group: JP Morgan downgrades to neutral with a target price of 610p.
Follow the stocks
